Nonetheless, newly identified mutations within the Gal-9 gene change the structure of binding sites within the CRDs of the protein, thereby attenuating T cell exhaustion and suppression of cancer progression relative to effects of wild-type Gal-9 [118]. This evidence concerns the gene LGALS9 and cancer.